These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 17377589)
1. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Caers J; Deleu S; Belaid Z; De Raeve H; Van Valckenborgh E; De Bruyne E; Defresne MP; Van Riet I; Van Camp B; Vanderkerken K Leukemia; 2007 Jul; 21(7):1580-4. PubMed ID: 17377589 [No Abstract] [Full Text] [Related]
2. Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype. Fairfield H; Dudakovic A; Khatib CM; Farrell M; Costa S; Falank C; Hinge M; Murphy CS; DeMambro V; Pettitt JA; Lary CW; Driscoll HE; McDonald MM; Kassem M; Rosen C; Andersen TL; van Wijnen AJ; Jafari A; Reagan MR Cancer Res; 2021 Feb; 81(3):634-647. PubMed ID: 33218968 [TBL] [Abstract][Full Text] [Related]
3. The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment. Lin B; Podar K; Gupta D; Tai YT; Li S; Weller E; Hideshima T; Lentzsch S; Davies F; Li C; Weisberg E; Schlossman RL; Richardson PG; Griffin JD; Wood J; Munshi NC; Anderson KC Cancer Res; 2002 Sep; 62(17):5019-26. PubMed ID: 12208756 [TBL] [Abstract][Full Text] [Related]
4. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Ribatti D; Nico B; Vacca A Oncogene; 2006 Jul; 25(31):4257-66. PubMed ID: 16518413 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Arnulf B; Lecourt S; Soulier J; Ternaux B; Lacassagne MN; Crinquette A; Dessoly J; Sciaini AK; Benbunan M; Chomienne C; Fermand JP; Marolleau JP; Larghero J Leukemia; 2007 Jan; 21(1):158-63. PubMed ID: 17096013 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow adiposity and multiple myeloma. Morris EV; Edwards CM Bone; 2019 Jan; 118():42-46. PubMed ID: 29548987 [TBL] [Abstract][Full Text] [Related]
7. The microenvironment and molecular biology of the multiple myeloma tumor. Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227 [TBL] [Abstract][Full Text] [Related]
8. [Mutual interaction between myeloma cells and bone marrow microenvironment]. Abe M Rinsho Ketsueki; 2009 Jun; 50(6):453-60. PubMed ID: 19571504 [No Abstract] [Full Text] [Related]
9. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566 [TBL] [Abstract][Full Text] [Related]
10. Chronic B cell malignancies and bone marrow microenvironment. Ghia P; Granziero L; Chilosi M; Caligaris-Cappio F Semin Cancer Biol; 2002 Apr; 12(2):149-55. PubMed ID: 12027587 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow plasma cell infiltration in multiple myeloma. de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051 [No Abstract] [Full Text] [Related]
13. [Multiple myeloma]. Krome S Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117 [No Abstract] [Full Text] [Related]
14. Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment. Caers J; Van Valckenborgh E; Menu E; Van Camp B; Vanderkerken K Bull Cancer; 2008 Mar; 95(3):301-13. PubMed ID: 18390410 [TBL] [Abstract][Full Text] [Related]
15. [Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications]. de la Rosa Alcaide MA; Hernández Nieto L; Hernández García MT; Brito Barroso ML Sangre (Barc); 1989 Aug; 34(4):313-4. PubMed ID: 2772787 [No Abstract] [Full Text] [Related]
16. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment. Giuliani N; Colla S; Morandi F; Rizzoli V Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473 [TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177 [TBL] [Abstract][Full Text] [Related]
18. Adipose, Bone, and Myeloma: Contributions from the Microenvironment. McDonald MM; Fairfield H; Falank C; Reagan MR Calcif Tissue Int; 2017 May; 100(5):433-448. PubMed ID: 27343063 [TBL] [Abstract][Full Text] [Related]
19. [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma]. Li J; Luo SK; Hong WD; Zhou ZH; Zou WY Ai Zheng; 2003 Apr; 22(4):346-9. PubMed ID: 12703985 [TBL] [Abstract][Full Text] [Related]
20. [Multiple myeloma with grape cell-like changes in almost all myeloma cells]. Mitsumori T; Nozaki Y; Nakajima K; Nagashima T; Kunitama M; Kirito K; Komatsu N Rinsho Ketsueki; 2007 Nov; 48(11):1453. PubMed ID: 18254205 [No Abstract] [Full Text] [Related] [Next] [New Search]